Skip to main content

Talasaz AmirAli's Form 4 filing

Guardant Health, Inc. (GH) · filed Dec 10, 2025

Accession no.
0001753159-25-000006
Filed
Dec 10, 2025
Trade date
Dec 8, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $10.5M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Talasaz AmirAliCIK 0001753159Director, Officer (Co-Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 8, 2025Common StockJOtherDisposed−387,946$0.00$082,854Indirect
Dec 8, 2025Common StockJOtherAcquired+193,973$0.00$0218,223Indirect
Dec 8, 2025Common StockJOtherAcquired+193,973$0.00$0218,223Indirect
Dec 8, 2025Common StockSSaleDisposed−15,000$104.21−$1,563,150203,223Indirect
Dec 8, 2025Common StockSSaleDisposed−30,760$105.34−$3,240,258.4172,463Indirect
Dec 8, 2025Common StockSSaleDisposed−4,240$106.00−$449,440168,223Indirect
Dec 8, 2025Common StockSSaleDisposed−15,000$104.21−$1,563,150203,223Indirect
Dec 8, 2025Common StockSSaleDisposed−30,760$105.34−$3,240,258.4172,463Indirect
Dec 8, 2025Common StockSSaleDisposed−4,240$106.00−$449,440168,223Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)